Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$503M |
| 2 |
Chevron
CVX
|
+$472M |
| 3 |
Vanguard Long-Term Bond ETF
BLV
|
+$374M |
| 4 |
EOG Resources
EOG
|
+$354M |
| 5 |
ARK Innovation ETF
ARKK
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.2B |
| 2 |
M&T Bank
MTB
|
+$313M |
| 3 |
iShares Core 60/40 Balanced Allocation ETF
AOR
|
+$304M |
| 4 |
Apple
AAPL
|
+$197M |
| 5 |
iShares Core 80/20 Aggressive Allocation ETF
AOA
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.55% |
| 2 | Healthcare | 8.23% |
| 3 | Financials | 6.88% |
| 4 | Industrials | 6.54% |
| 5 | Consumer Discretionary | 5.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
John B. Sanfilippo & Son
JBSS
$965M
| $1.57M | ﹤0.01% |
16,155
+1,852
| +13% | +$165K |
|
2927
PUT
Danaher
DHR
$147B
| $1.56M | ﹤0.01% |
6,994
+6,204
| +785% | +$1.41M |
|
2928
Editas Medicine
EDIT
$432M
| $1.56M | ﹤0.01% |
215,136
-56,868
| -21% | -$506K |
|
|
DOC
2929
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.56M | ﹤0.01% |
104,394
+28,019
| +37% | +$423K |
|
2930
Nuveen New York Quality Municipal Income Fund
NAN
$373M
| $1.56M | ﹤0.01% |
141,120
-5,758
| -4% | -$63.1K |
|
|
TMHC
2931
DELISTED
Taylor Morrison
TMHC
| $1.55M | ﹤0.01% |
40,499
-19,359
| -32% | -$680K |
|
2932
Revolution Medicines
RVMD
$44.4B
| $1.55M | ﹤0.01% |
71,416
+69,610
| +3,854% | +$1.71M |
|
|
AMJ
2933
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.55M | ﹤0.01% |
69,648
-3,557
| -5% | -$80.3K |
|
|
RMMZ
2934
RiverNorth Managed Duration Municipal Income Fund II
RMMZ
$126M
| $1.54M | ﹤0.01% |
102,281
+66,615
| +187% | +$1.05M |
|
2935
WisdomTree International MidCap Dividend Fund
DIM
$168M
| $1.54M | ﹤0.01% |
26,353
-337
| -1% | -$19.7K |
|
2936
First Mid Bancshares
FMBH
$1.36B
| $1.54M | ﹤0.01% |
56,563
+3,386
| +6% | +$103K |
|
2937
Independent Bank
INDB
$3.97B
| $1.54M | ﹤0.01% |
23,420
+6,203
| +36% | +$474K |
|
2938
BlackRock MuniAssets Fund
MUA
$519M
| $1.53M | ﹤0.01% |
145,720
+5,756
| +4% | +$62.3K |
|
2939
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.53M | ﹤0.01% |
183,949
+174,123
| +1,772% | +$1.68M |
|
2940
Fate Therapeutics
FATE
$322M
| $1.53M | ﹤0.01% |
268,927
+218,236
| +431% | +$1.32M |
|
2941
Telephone and Data Systems
TDS
$3.84B
| $1.52M | ﹤0.01% |
145,016
+19,350
| +15% | +$226K |
|
2942
Chegg
CHGG
$94.8M
| $1.52M | ﹤0.01% |
93,305
+40,269
| +76% | +$753K |
|
2943
Iovance Biotherapeutics
IOVA
$2.9B
| $1.51M | ﹤0.01% |
247,917
+210,126
| +556% | +$1.45M |
|
2944
Viking Therapeutics
VKTX
$4.02B
| $1.51M | ﹤0.01% |
90,895
+89,391
| +5,944% | +$923K |
|
2945
Gates Industrial Corporation Ltd.
GTES
$7.19B
| $1.51M | ﹤0.01% |
108,794
+9,803
| +10% | +$131K |
|
2946
Flywire
FLYW
$2.11B
| $1.51M | ﹤0.01% |
51,430
+48,580
| +1,705% | +$1.28M |
|
|
EXAI
2947
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $1.51M | ﹤0.01% |
284,716
+284,116
| +47,353% | +$1.93M |
|
2948
SFL Corp
SFL
$1.58B
| $1.51M | ﹤0.01% |
158,702
+32,442
| +26% | +$320K |
|
2949
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$47.2M
| $1.51M | ﹤0.01% |
31,914
-85,873
| -73% | -$4.03M |
|
|
MAXR
2950
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $1.5M | ﹤0.01% |
29,465
-84,994
| -74% | -$4.35M |
|
Similar funds
Wells Fargo's Q1 2023 Portfolio in Review
As of Q1 2023, Wells Fargo held 7,943 positions worth $347B, up 4.2% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Wells Fargo's Q1 2023 filing shows 427 new, 3,865 increased, 2,015 reduced and 474 closed positions. Its largest new stake was GE HealthCare: 686,371 shares worth $56.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.2B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q1 2023 buy was GE HealthCare: 686,371 shares worth $56.3M.
- Wells Fargo added most to Invesco QQQ Trust in Q1 2023, an estimated $503M increase.
- Wells Fargo's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.2B.
- Wells Fargo fully exited STORE Capital Corporation in Q1 2023, selling an estimated $25.9M.
- Wells Fargo's ten largest holdings make up 17% of its $347B portfolio in Q1 2023.
- Wells Fargo opened 427 new positions and closed 474 in Q1 2023.
- Wells Fargo's portfolio value rose 4.2% quarter-over-quarter to $347B.
Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.